Andrographolide inhibits the activation of spinal microglia and ameliorates mechanical allodynia.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 115, doi. 10.1007/s11011-023-01325-0
- By:
- Publication type:
- Article
Works matching IS 08857490 AND DT 2024 AND VI 39 AND IP 1
Results: 19
1
2
Genomic insights and advanced machine learning: characterizing autism spectrum disorder biomarkers and genetic interactions.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 29, doi. 10.1007/s11011-023-01322-3
- By:
- Publication type:
- Article
3
Network pharmacology-based approach to understand the effect and mechanism of chrysophanol against cognitive impairment in Wilson disease.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 89, doi. 10.1007/s11011-023-01321-4
- By:
- Publication type:
- Article
4
Shark fish oil prevents scopolamine-induced memory impairment in an experimental model.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 15, doi. 10.1007/s11011-023-01320-5
- By:
- Publication type:
- Article
5
Molecular dynamics exploration of Lupenone: therapeutic implications for glioblastoma multiforme and alzheimer's amyloid beta pathogenesis.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 77, doi. 10.1007/s11011-023-01319-y
- By:
- Publication type:
- Article
6
Combination chemotherapy in rodents: a model for chemotherapy-induced neuropathic pain and pharmacological screening.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 43, doi. 10.1007/s11011-023-01315-2
- By:
- Publication type:
- Article
7
Plasma metabolomics reveals the intervention mechanism of different types of exercise on chronic unpredictable mild stress-induced depression rat model.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s11011-023-01310-7
- By:
- Publication type:
- Article
8
Integrated bioinformatics and network pharmacology identifying the mechanisms and molecular targets of Guipi Decoction for treatment of comorbidity with depression and gastrointestinal disorders.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 183, doi. 10.1007/s11011-023-01308-1
- By:
- Publication type:
- Article
9
Correction to: Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
10
Echinacea purpurea extract intervention for counteracting neurochemical and behavioral changes induced by bifenthrin.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 101, doi. 10.1007/s11011-023-01303-6
- By:
- Publication type:
- Article
11
Mechanistic interplay of different mediators involved in mediating the anti-depressant effect of isoflavones.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 199, doi. 10.1007/s11011-023-01302-7
- By:
- Publication type:
- Article
12
Ginger (Zingiber Officinale Roscoe) ameliorates ethanol-induced cognitive impairment by modulating NMDA and GABA-A receptors in rat hippocampus.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 67, doi. 10.1007/s11011-023-01301-8
- By:
- Publication type:
- Article
13
Correction to: Paeoniforin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
14
Potential novel mechanism of selenium on cognition.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 249, doi. 10.1007/s11011-023-01289-1
- By:
- Publication type:
- Article
15
Intermittent fasting and Alzheimer's disease—Targeting ketone bodies as a potential strategy for brain energy rescue.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 129, doi. 10.1007/s11011-023-01288-2
- By:
- Publication type:
- Article
16
Classical Hereditary galactosemia: findings in patients and animal models.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 239, doi. 10.1007/s11011-023-01281-9
- By:
- Publication type:
- Article
17
Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 173, doi. 10.1007/s11011-023-01278-4
- By:
- Publication type:
- Article
18
Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 147, doi. 10.1007/s11011-023-01271-x
- By:
- Publication type:
- Article
19
Understanding the multifaceted role of miRNAs in Alzheimer's disease pathology.
- Published in:
- Metabolic Brain Disease, 2024, v. 39, n. 1, p. 217, doi. 10.1007/s11011-023-01265-9
- By:
- Publication type:
- Article